NCT06079814

Brief Summary

The aim of this research is to conduct a two-group randomized controlled intervention study to determine the effect of virtual reality applications on pain and anxiety during cystoscopy. The study population will consist of patients who have applied to the urology outpatient clinic of a University Hospital for cystoscopy. The study sample will be composed of patients who volunteer to participate in the study and meet the criteria during the planned dates of the research. Data will be collected using a 'Personal Information Form' created by the researcher through a literature review, the 'Visual Analog Scale' (VAS) for assessing pain, and the 'State Anxiety Inventory' (SAI) for assessing anxiety.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

October 10, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 12, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2024

Completed
Last Updated

March 1, 2024

Status Verified

February 1, 2024

Enrollment Period

11 months

First QC Date

October 2, 2023

Last Update Submit

February 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • The effect of virtual reality applications on pain during cystoscopy

    The patient's pain will be assessed using the 'Visual Analog Scale (VAS).' This scale involves marking on a 10 cm vertical or horizontal line, with one end indicating no pain at all and the other end indicating the most severe pain, to assess and measure the level of pain.

    30 minutes after the procedure

  • The effect of virtual reality applications on anxiety during cystoscopy

    Procedure related anxiety will be assessed using the 'State Anxiety Inventory.' This inventory consists of a total of 20 items and the scoring ranges from 20 to 80 points. The higher the total score obtained from the scale, the higher the level of anxiety experienced by the individual is interpreted.

    30 minutes after the procedure

Study Arms (2)

experiment group

EXPERIMENTAL

Patients will wear virtual reality glasses 10 minutes before cystoscopy. The content chosen by the patient (there will be three options) will be watched throughout the procedure.

Other: virtual reality intervention

control group

NO INTERVENTION

Standard procedure.

Interventions

Patients will be shown content through the patient's virtual reality glasses throughout the cystoscopy procedure.

experiment group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being literate,
  • Being conscious,
  • Ability to understand and speak Turkish and not have hearing or visual impairment,
  • Agreeing to participate in the research.

You may not qualify if:

  • Having a diagnosed psychiatric and mental illness,
  • Patients diagnosed with epilepsy (due to the risk of virtual reality glasses triggering epileptic seizures),
  • Patients who do not want to continue the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cukurova University

Adana, 01030, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

PainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinic Nurse

Study Record Dates

First Submitted

October 2, 2023

First Posted

October 12, 2023

Study Start

October 10, 2023

Primary Completion

September 10, 2024

Study Completion

December 10, 2024

Last Updated

March 1, 2024

Record last verified: 2024-02

Locations